Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China
· Delayed Price · Currency is CNY 14.23
+0.28 (2.01%)
Apr 29, 2026, 3:04 PM CST
SHE:002275 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 8,361 | 8,285 | 8,866 | 8,514 | 7,570 | 9,728 | Upgrade
|
| Market Cap Growth | 1.21% | -6.56% | 4.14% | 12.46% | -22.18% | 13.41% | Upgrade
|
| Enterprise Value | 7,154 | 7,206 | 7,964 | 7,554 | 6,484 | 8,505 | Upgrade
|
| Last Close Price | 14.23 | 14.10 | 14.53 | 13.42 | 11.80 | 14.11 | Upgrade
|
| PE Ratio | 19.23 | 19.13 | 17.00 | 20.21 | 22.97 | 28.30 | Upgrade
|
| Forward PE | - | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | Upgrade
|
| PS Ratio | 4.09 | 4.05 | 4.04 | 3.92 | 3.86 | 5.59 | Upgrade
|
| PB Ratio | 2.62 | 2.60 | 2.95 | 3.02 | 2.69 | 3.43 | Upgrade
|
| P/TBV Ratio | 2.74 | 2.72 | 3.10 | 3.20 | 2.87 | 3.66 | Upgrade
|
| P/FCF Ratio | 13.46 | 13.34 | 17.52 | 18.01 | 16.23 | 36.55 | Upgrade
|
| P/OCF Ratio | 11.81 | 11.70 | 15.07 | 15.50 | 14.32 | 23.71 | Upgrade
|
| EV/Sales Ratio | 3.50 | 3.52 | 3.63 | 3.48 | 3.31 | 4.88 | Upgrade
|
| EV/EBITDA Ratio | 10.86 | 11.00 | 13.94 | 13.13 | 15.73 | 20.59 | Upgrade
|
| EV/EBIT Ratio | 12.59 | 12.68 | 16.58 | 16.41 | 20.54 | 26.06 | Upgrade
|
| EV/FCF Ratio | 11.52 | 11.60 | 15.74 | 15.98 | 13.90 | 31.95 | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.16 | 0.20 | 0.19 | 0.17 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 0.78 | 0.78 | 1.01 | 0.92 | 1.08 | 1.41 | Upgrade
|
| Debt / FCF Ratio | 0.83 | 0.83 | 1.17 | 1.12 | 1.00 | 2.29 | Upgrade
|
| Net Debt / Equity Ratio | -0.38 | -0.38 | -0.36 | -0.31 | -0.34 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.84 | -1.84 | -1.89 | -1.52 | -2.33 | -2.64 | Upgrade
|
| Net Debt / FCF Ratio | -1.94 | -1.94 | -2.14 | -1.86 | -2.06 | -4.10 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.54 | 0.55 | 0.49 | 0.44 | Upgrade
|
| Inventory Turnover | 2.38 | 2.38 | 2.63 | 2.41 | 2.17 | 1.91 | Upgrade
|
| Quick Ratio | 2.69 | 2.69 | 2.33 | 2.09 | 2.39 | 2.56 | Upgrade
|
| Current Ratio | 3.01 | 3.01 | 2.58 | 2.46 | 2.71 | 2.96 | Upgrade
|
| Return on Equity (ROE) | 13.97% | 13.97% | 17.90% | 14.96% | 11.66% | 11.86% | Upgrade
|
| Return on Assets (ROA) | 8.37% | 8.37% | 7.35% | 7.28% | 4.90% | 5.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 22.09% | 23.44% | 20.13% | 19.74% | 12.95% | 15.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.40% | 16.40% | 14.80% | 15.10% | 10.10% | 10.00% | Upgrade
|
| Earnings Yield | 5.18% | 5.23% | 5.88% | 4.95% | 4.35% | 3.53% | Upgrade
|
| FCF Yield | 7.43% | 7.50% | 5.71% | 5.55% | 6.16% | 2.74% | Upgrade
|
| Dividend Yield | 3.94% | - | 4.13% | 4.47% | 6.78% | 6.38% | Upgrade
|
| Payout Ratio | 78.74% | 78.74% | 64.45% | 101.54% | 173.24% | 132.00% | Upgrade
|
| Buyback Yield / Dilution | 0.11% | 0.11% | -0.15% | 0.56% | -2.72% | 0.74% | Upgrade
|
| Total Shareholder Return | 4.06% | 0.11% | 3.98% | 5.03% | 4.06% | 7.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.